# Modulation of Regional Brain Activation in Schizophrenic Patients by Pharmacological Therapy

> **NCT00419653** · PHASE4 · TERMINATED · sponsor: **University of Jena** · enrollment: 19 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Amisulpride
- **DRUG:** Olanzapine
- **DRUG:** Haloperidol

## Key facts

- **NCT ID:** NCT00419653
- **Lead sponsor:** University of Jena
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-01
- **Primary completion:** 2007-09
- **Final completion:** 2007-09
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Recruitment issues
- **Last updated:** 2008-09-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00419653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00419653, "Modulation of Regional Brain Activation in Schizophrenic Patients by Pharmacological Therapy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00419653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*